The Association of Clinical Research Organizations (ACRO) has testified in a hearing before the U.S. International Trade Commission (ITC) on the decline of clinical trial activity in India, a decrease more than 60% since 2010, as being the result of a “confusing, inconsistent, and arbitrary” regulatory environment.   ACRO’s vice president of public affairs, John Lewis, testified, “To be clear, ACRO members are committed to conducting safe, ethical, high-quality clinical research across the globe...